Before clinical symptoms appear in individuals with mild cognitive impairment (MCI) or AD, the brain already shows a decline in glucose metabolism, and there is evidence suggesting that ApoE4 may play a key role in this process [109, 110]. The gene discussed is APOE; the disease is Alzheimer disease.